Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1). - Wikidata - awgldk - TriplyDB

Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1).

Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1).

http://www.wikidata.org/entity/Q37598626

about

Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients PharmGKB summary: very important pharmacogene information for SLC22A1 Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase.OCT1 and imatinib transport in CML: is it clinically relevant?Role of SLC22A1 polymorphic variants in drug disposition, therapeutic responses, and drug-drug interactions.Expression of organic cation transporter 1 (OCT1): unique patterns of indirect regulation by nuclear receptors and hepatospecific gene regulation.The Role of Transporters in the Toxicity of Chemotherapeutic Drugs: Focus on Transporters for Organic Cations.Advances and challenges in hereditary cancer pharmacogenetics.Pharmacogenetics and Pharmacogenomics of Targeted Therapeutics in Chronic Myeloid Leukemia.Molecular Response to Imatinib and Its Correlation with mRNA Expression Levels of Imatinib Influx Transporter (OCT1) in Indian Chronic Myeloid Leukemia Patients MicroRNA-212/ABCG2-axis contributes to development of imatinib-resistance in leukemic cells.Fine Mapping and Functional Analysis Reveal a Role of SLC22A1 in Acylcarnitine Transport.Inhibition of CREB phosphorylation by conjugates of adenosine analogues and arginine-rich peptides, inhibitors of PKA catalytic subunit.

P2860

Q26781539-77E37E82-2724-45E7-AB3F-17E403E4A3A3 Q30313870-A9BE30A9-5E6C-44EE-9C39-DEDC2CB21C0A Q33671763-7A9429EE-CBF7-40EF-88E6-E242FC06AAC6 Q36184500-5E464D77-089D-4B30-97E2-10930B75BD96 Q38540022-E28CE6B4-46A3-4D0B-8F32-FFF07BC130DB Q38622785-131AEDFB-7EF2-4647-A1EE-31BAAEFA0FE4 Q38859468-43D2FF9B-7F54-4F97-B02E-B84CDDE1A06B Q38888345-E0F47754-7EEE-4072-BD0F-39B314899E2E Q38948499-1E81269C-1ECB-4D56-9408-4088CAF27078 Q39429836-A71F0A28-4D51-4140-ADE8-90DC7DE93602 Q47117554-F8671045-A725-4E30-869E-4970EF47396B Q47165781-6CD7CAE1-50A4-4826-BC1D-4321ED91C890 Q47752654-AA491D67-C685-454E-85E9-BCF1F27C3C2F Q51745511-A9B3615C-AAE0-4997-B493-619B4349F6E5

P2860

Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1).

http://www.wikidata.org/entity/Q37598626

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cellular uptake of imatinib in ...... c cation transporter 1 (OCT1).

@en

Cellular uptake of imatinib in ...... n organic cation transporter 1

@nl

type

label

Cellular uptake of imatinib in ...... c cation transporter 1 (OCT1).

@en

Cellular uptake of imatinib in ...... n organic cation transporter 1

@nl

prefLabel

Cellular uptake of imatinib in ...... c cation transporter 1 (OCT1).

@en

Cellular uptake of imatinib in ...... n organic cation transporter 1

@nl

P1433

Q37598626-FD9C4D40-A6BA-44E3-A047-9F016E7A8C99

P1476

Q37598626-AFA6434E-6412-496E-ACDE-A0366FD28716

P2093

Q37598626-197C28D4-5F8D-40B2-9CA8-04972B80B05D

Q37598626-2F4CB824-1DAD-45BA-9497-021F02359570

Q37598626-42417DF2-29A6-4A59-BC52-968CC889B67B

Q37598626-4ED78FE5-C1EC-45C7-A049-7C74C5970773

Q37598626-7F562B2A-7070-4B73-AE39-DB1D7CACB09D

Q37598626-C7B02256-6394-44D1-A25D-FDD779C11F25

Q37598626-CA53135B-3695-4766-9801-1921B9B24677

Q37598626-D611C2FD-DFA4-4DAB-8041-2C4D438C4BD6

Q37598626-DC6AF0B3-CCEA-4108-9AB3-3076B8DF955C

P2860

Q37598626-034AABA9-58EF-4277-BFF4-86D435820CFC

Q37598626-0802ABCC-66A8-47CF-ACC1-B3DA4D627D9E

Q37598626-091043F7-6180-4F06-B339-C142024E9614

Q37598626-0A89CD26-9B3C-418C-976A-048750D08FF0

Q37598626-11B7C616-CAC5-4FD4-9EB4-C7E23557B387

Q37598626-235B4B4B-1B43-4B25-93AD-C0D26F1A66F2

Q37598626-238AF9E4-CF7F-4121-AD45-E129F4C363F3

Q37598626-2C45FFE2-1F4B-407F-AC14-7148F86F6D56

Q37598626-30479C07-27D8-4576-9C73-89914DFF522B

Q37598626-320FFE2E-B5ED-4AB5-A6A1-D2645896CB8F

P304

Q37598626-3AA5F9ED-5FD7-4D2D-B61A-2061E69203BB

P31

Q37598626-10DF0B84-58F4-45F8-A35A-233D6C2939E1

P356

Q37598626-0A7E6FDF-8031-495C-81C8-FC7F8F329C64

P407

Q37598626-53269708-55F3-401C-8750-214B12D682CD

P433

Q37598626-8879B2A4-B179-4AC7-9E1A-F77F7D51DE60

P478

Q37598626-3017A23C-1B81-47EF-AB78-9873BAEBCD51

P50

Q37598626-0404DD39-7F3E-42BC-83E3-23D47D49C82D

Q37598626-2F76B242-AB67-45A2-AA05-38C48DA3D5DC

Q37598626-5DF15558-5241-49C2-8454-C613AEF46F7A

Q37598626-695C5B1E-C9EA-4B2B-A8CE-5523B440AF75

Q37598626-78124DDA-6D42-450D-8D9B-D42DF98593CE

Q37598626-E1553AA6-D193-47E0-AB5E-0B48EDF91E3A

Q37598626-FB6D7D3D-F912-497C-A290-03F4A4F34E70

P577

Q37598626-9F58CFF7-5A3C-44AC-88C5-56B3605D1BA8

P698

Q37598626-B66BA316-7F7E-4DBB-9381-801A6C642F13

P921

Q37598626-4099437B-13E3-4B89-8A4B-9703368D0E69

P932

Q37598626-E69C1FFD-A1E9-49EC-8B7A-DD2C3016C22A

P356

1078-0432.CCR-13-1999

P1433

Clinical Cancer Research

P1476

Cellular uptake of imatinib in ...... c cation transporter 1 (OCT1).

@en

P2093

Christiane Pott

http://www.w3.org/2001/XMLSchema#string

Christopher Volk

http://www.w3.org/2001/XMLSchema#string

Heiko van der Kuip

http://www.w3.org/2001/XMLSchema#string

Hermann Koepsell

http://www.w3.org/2001/XMLSchema#string

Matthias Schwab

http://www.w3.org/2001/XMLSchema#string

Michael Kneba

http://www.w3.org/2001/XMLSchema#string

Oliver Bruhn

http://www.w3.org/2001/XMLSchema#string

Peter Ruth

http://www.w3.org/2001/XMLSchema#string

Shuiying Hu

http://www.w3.org/2001/XMLSchema#string

P2860

Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs)

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.

Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib.

A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib.

Drug transporters and imatinib treatment: implications for clinical practice.

Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene

P304

985-994

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-13-1999

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Heiko van der Kuip

Elke Schaeffeler

Sharyn D. Baker

Ingolf Cascorbi

Alex Sparreboom

P577

2013-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24352644

http://www.w3.org/2001/XMLSchema#string

P921

P932

3932302

http://www.w3.org/2001/XMLSchema#string